European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Date of authorisation: 11/02/2021, Revision: 18, Status: Authorised

Submitted by Anonymous (not verified) on 15 December 2025 - 14:55

Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Date of authorisation: 11/02/2021, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Coagadex, human coagulation factor X, Date of authorisation: 16/03/2016, Revision: 12, Status: Authorised

Submitted by Anonymous (not verified) on 15 December 2025 - 14:35

Human medicines European public assessment report (EPAR): Coagadex, human coagulation factor X, Date of authorisation: 16/03/2016, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Remicade, infliximab, Date of authorisation: 13/08/1999, Revision: 69, Status: Authorised

Submitted by Anonymous (not verified) on 15 December 2025 - 14:20

Human medicines European public assessment report (EPAR): Remicade, infliximab, Date of authorisation: 13/08/1999, Revision: 69, Status: Authorised

ESIM Summer 2026

Submitted by Catalina on 15 December 2025 - 12:23

We are delighted to announce the European Summer School of Internal Medicine (ESIM) 2026!

Following the great success of last year’s event, the Summer ESIM 2026 will take place from 31 May to 6 June 2026 at the Astir Egnatia Hotel and the University Hospital of Alexandroupolis, in the beautiful coastal city of Alexandroupolis, Greece.

Human medicines European public assessment report (EPAR): Repatha, evolocumab, Date of authorisation: 17/07/2015, Revision: 27, Status: Authorised

Submitted by Anonymous (not verified) on 15 December 2025 - 11:40

Human medicines European public assessment report (EPAR): Repatha, evolocumab, Date of authorisation: 17/07/2015, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Levetiracetam Hospira, levetiracetam, Date of authorisation: 07/01/2014, Revision: 28, Status: Authorised

Submitted by Anonymous (not verified) on 15 December 2025 - 11:36

Human medicines European public assessment report (EPAR): Levetiracetam Hospira, levetiracetam, Date of authorisation: 07/01/2014, Revision: 28, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness